Menopause – Medxy AI

Long-Term Fracture Risk After Menopausal Hormone Therapy: New Insights from a Landmark Study

By MedXY 07/30/2025

Large-scale UK data reveal a transient increase but sustained long-term reduction in fracture risk after discontinuing menopausal HRT, challenging prior assumptions and guiding future clinical decisions.

Wellness & Lifestyle

Rethinking Menopausal Hormone Therapy: Experts Urge FDA to Revise Outdated Warnings

By MedXY 07/29/2025

Leading experts call on the FDA to update boxed warnings on menopausal hormone therapies, arguing current labels are outdated and deter women from effective, safe treatments.

Wellness & Lifestyle

Enhanced Weight Loss for Menopausal Women: The Role of Tirzepatide and Hormone Therapy

By MedXY 07/29/2025

A new study reveals combining tirzepatide and hormone therapy significantly boosts weight loss in postmenopausal women, offering a promising approach to managing obesity-related health risks.

Wellness & Lifestyle

FDA Extends Review of Bayer’s Elinzanetant for Menopause Symptoms

By MedXY 07/28/2025

The FDA delays its review of Bayer's elinzanetant, a novel treatment for menopause-related vasomotor symptoms, by 90 days, citing the need for additional data assessment.